Marion Delenclos

Marion Delenclos

Auto-generated profile, based on publicly available information

Marion Delenclos

Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
NZNa Zhao
Na Zhao
OAOlivia N. Attrebi
Olivia N. Attrebi
YRYingxue Ren
Yingxue Ren
WQWenhui Qiao
Wenhui Qiao
BSBerkiye Sonustun
Berkiye Sonustun
GBGuojun Bu
Guojun Bu
APOE4 exacerbates α-synuclein pathology in a synucleinopathy mouse model, and APOE4 genotype associates with increased α-synuclein pathology in humans.

30 July 2019 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
MDMarion Delenclos
Marion Delenclos
JBJeremy D. Burgess
Jeremy D. Burgess
ALAgaristi Lamprokostopoulou
Agaristi Lamprokostopoulou
Tiago OuteiroTiago Outeiro
Tiago Outeiro
KVKOSTAS VEKRELLIS
KOSTAS VEKRELLIS
PMPamela J. McLean
Pamela J. McLean
Misfolding and aggregation of alpha‐synuclein (α‐synuclein) with concomitant cytotoxicity is a hallmark of Lewy body related disorders such as Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Although it plays a pivotal role in pathogenesis and disease progression, the function of α‐synuclein and the molecular mechanisms underlying α‐synuclein‐induced neurotoxicity in these diseases are still elusive. Many in vitro and in vivo experimental models mimicking α‐synuclein pathology such as oligomerization, toxicity and more recently neuronal propagation have been generated over the years. In particular, cellular models have been crucial for our comprehension of the pathogenic process of the disease and are beneficial for screening of molecules capable of modulating α‐synuclein toxicity. Here, we review α‐synuclein based cell culture models that reproduce some features of the neuronal populations affected in patients, from basic unicellular organisms to mammalian cell lines and primary neurons, to the cutting edge models of patient‐specific cell lines. These reprogrammed cells known as induced pluripotent stem cells (iPSCs) have garnered attention because they closely reproduce the characteristics of neurons found in patients and provide a valuable tool for mechanistic studies. We also discuss how different cell models may constitute powerful tools for high‐throughput screening of molecules capable of modulating α‐synuclein toxicity and prevention of its propagation. image This article is part of the Special Issue “Synuclein”.